Ignite Creation Date:
2024-05-06 @ 7:02 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05876780
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-09-21
First Post:
2023-05-17
Brief Title:
A Gene Transfer Single Dose Study to Evaluate the Safety Tolerability and Efficacy of SRP-9003 in Non-Ambulatory and Ambulatory Participants With Limb Girdle Muscular Dystrophy Type 2ER4 Beta-Sarcoglycan β-SG Deficiency
Sponsor:
Sarepta Therapeutics Inc
Organization:
Sarepta Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-19
Start Date Type:
ACTUAL
Primary Completion Date:
2028-08-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-08-28
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-17
First Submit QC Date:
May 17 2023
Study First Post Date:
2023-05-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-18
Last Update Post Date:
2023-09-21
Last Update Post Date Type:
ACTUAL